Diabetes News

Medindia's Press Release’ section provides the latest press release on Diabetes from across the world for the global audience. This page links to 1367 Diabetes press releases.

Praetego Awarded $0.3M by National Eye Institute to Advance Novel Oral Drug for Diabetic Retinopathy

DURHAM, N.C. , March 1, 2023 /PRNewswire/ -- ( https:www.praetego.com/ ) Praetego Inc, a pharmaceutical company protecting patients from neurodegenerative diseases related to aging, is pleased to announce a $0.3M STTR award from the ...


Spinal Cord Stimulation May Help Diabetic Neuropathy

MINNEAPOLIS , March 1, 2023 /PRNewswire/ -- People with painful diabetic neuropathy may be able to get relief from high-frequency spinal cord stimulation, according to a preliminary study released February 28, 2023 , that will be ...

Innovation Zed Announces CE Mark of New Technology InsulCheck DOSE: An Add-on Device That Automatically Logs the Time and Dialled Dosage for Insulin Pen Users

DUBLIN, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Innovation Zed, an Irish R&D company specialising in the design, development and manufacturing of medical technologies, announced today it has secured a CE Mark for the InsulCheck DOSE add-on device. ...

Switching Patterns Among Diabetic Macular Edema: Regeneron's Eylea Withstands the Evolving DME Switch Landscape

With the DME treatment landscape evolving, ophthalmologists have the opportunity to explore more novel approaches in hopes of easing treatment burden. But will they take the plunge and stray from the tried-and-true options? EXTON, Pa. , ...

Jmir Diabetes | Clinical Utility of Digital Therapeutic Intervention With Type 2 Diabetes

Patients with type 2 diabetes mellitus (T2DM) that have elevated levels of blood glucose and glycated hemoglobin are at higher risk of macro- and microvascular complications. TORONTO and PHILADELPHIA , Feb. 8, 2023 /PRNewswire/ --  ...

Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 3 Clinical Trials of Ecnoglutide (XW003), a Long-acting GLP-1 analog, for the Treatment of Type 2 Diabetes in China

HANGZHOU, China and SAN FRANCISCO , Jan. 30, 2023 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, announced ...

AEYE Health announces best-in-class results, proving AI software is capable of predicting the future development of diabetic retinopathy in patients before diagnosable symptoms manifest

NEW YORK , Jan. 24, 2023 /PRNewswire/ --  AEYE Health , a leading AI company for retinal-based diagnostics, is pleased to announce the recent publication of its paper describing the development of a deep learning algorithm which can ...

Novo Nordisk announces FDA approval of label update for Rybelsus® (semaglutide) allowing use as a first-line option for adults with type 2 diabetes

People living with type 2 diabetes can now take Rybelsus ® , the first and only oral glucagon-like peptide-1 (GLP-1) analog, along with diet and exercise, as initial therapy to help lower their A1C 1,2 Since its approval, Rybelsus ® ...

Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (DREAMS-2) of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes

ROCKVILLE, Md. and SUZHOU, China , Jan. 10, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...

Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (DREAMS-1) of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes

ROCKVILLE, Md. and SUZHOU, China , Jan. 9, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...

Diabetes News »

Prediabetes: A Ticking Time Bomb for Early Heart and Kidney Disease

Prediabetes: A Ticking Time Bomb for Early Heart and Kidney Disease

Prediabetes raises the risk of dying before age 75, especially from heart disease , kidney disease, and acute diabetic complications. Participants with the stricter definition of prediabetes had 2.6 times the risk of dying from acute diabetic ...

MiniMed Extended Infusion Set Could Improve Diabetes Care Sustainability

MiniMed Extended Infusion Set Could Improve Diabetes Care Sustainability

Medical waste from diabetes care, especially from the infusion sets and reservoirs used with insulin pumps, significantly impacts sustainability due to their reliance on single-use plastics ( ). Medtronic's Innovation in Extended ...

Hidden Risks of Early-Onset Diabetes

Hidden Risks of Early-Onset Diabetes

Concerning link between diabetes diagnosed in youth and an increased risk of dementia and related neurodegenerative diseases has been highlighted by a new study by researchers in the Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center at ...

High Prevalence of Eating Disorder Symptoms in Insulin-Dependent Diabetics

High Prevalence of Eating Disorder Symptoms in Insulin-Dependent Diabetics

A recent meta-analysis conducted at the University of Eastern Finland reveals that 25% of patients aged 16 and above with insulin -dependent diabetes show signs of eating disorder symptoms. Alongside common symptoms like binge eating and food ...

Potential Targeted Therapy for Type I Diabetes: Monoclonal Antibodies

Potential Targeted Therapy for Type I Diabetes: Monoclonal Antibodies

Type 1 diabetes, known as T1D, is characterized by an autoimmune response where harmful lymphocytes attack autoantigens found in the pancreatic islets, resulting in the loss of insulin-producing beta cells in the pancreas. The ...

More Diabetes News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.